Des deux arbitraires, absolu et relatif, à un arbitraire «primaire» : Le fait linguistique et le devenir du signe chez Saussure : Mélanges en hommage à Claudine Normand = From the two types of arbitrariness, absolute and relative, to a primary arbitrariness : The linguistic fact and the gradual change of sign in Saussure : Miscellany in homage to Claudine NormandSUENAGA, A.Cahiers Ferdinand de Saussure. 1999, Num 52, pp 189-200, issn 0068-516XArticle

STUDIES ON SYNTHETIC SWEETENING AGENTS. XVII. METABOLISM OF SODIUM CYCLAMATE. 6. INFLUENCE OF NEOMYCIN AND SULFAGUANIDINE ON METABOLISM OF SODIUM CYCLAMATE = ETUDES SUR LES AGENTS EDULCORANTS SYNTHETIQUES. XVII. METABOLISME DU CYCLAMATE DE SODIUM. 6. INFLUENCE DE LA NEOMYCINE ET DE LA SULFAGUANIDINE SUR LE METABOLISME DU CYCLAMATE DE SODIUMSUENAGA A; KOJIMA S; ICHIBAGASE H et al.1972; CHEM. PHARM. BULL.; JAP.; DA. 1972; VOL. 20; NO 7; PP. 1357-1361; BIBL. 9 REF.Serial Issue

ETUDE BIOPHARMACEUTIQUE DU PYRIDINOL CARBAMATE. I. EFFET DE L'ADMINISTRATION CONTINUE DE PYRIDINOL CARBAMATE SUR L'EXCRETION RENALE DES SULFONAMIDES CHEZ LE LAPINICHIBAGASE H; IMAMURA Y; SUENAGA A et al.1978; YAKUGAKU ZASSHI, J. PHARM. SOC. JAP.; JPN; DA. 1978; VOL. 98; NO 10; PP. 1398-1402; ABS. ENG; BIBL. 12 REF.Article

ETUDE BIOPHARMACEUTIQUE DU PYRIDINOL CARBAMATE. II. ISOLEMENT ET IDENTIFICATION DE SES METABOLITES URINAIRES CHEZ LE LAPINICHIBAGASE H; IMAMURA Y; SUENAGA A et al.1978; YAKUGAKU ZASSHI, J. PHARM. SOC. JAP.; JPN; DA. 1978; VOL. 98; NO 10; PP. 1402-1405; ABS. ENG; BIBL. 9 REF.Article

ETUDE BIOPHARMACEUTIQUE DU PYRIDINOL CARBAMATE. III. EFFET DE SON ADMINISTRATION CONTINUE SUR L'EXCRETION RENALE DE LA PHENOLPHTALEINE, DE L'ACIDE P-AMINOHIPPURIQUE, DU MANNITOL ET DE L'INULINE CHEZ LES LAPINSICHIBAGASE H; IMAMURA Y; SUENAGA A et al.1978; YAKUGAKU ZASSHI, J. PHARM. SOC. JAP.; JPN; DA. 1978; VOL. 98; NO 10; PP. 1406-1409; ABS. ENG; BIBL. 17 REF.Article

STUDIES ON SYNTHETIC SWEETNING AGENTS. XVI. METABOLISM OF SODIUM CYCLAMATE. THE METABOLISM OF SODIUM CYCLAMATE IN RABBITS AND RATS AFTER PROLONGED ADMINISTRATION OF SODIUM CYCLAMATE = ETUDES SUR LES AGENTS EDULCORANTS SYNTHETIQUES. XVI. METABOLISME DU CYCLAMATE DE SODIUM. LE METABOLISME DU CYCLAMATE DE SODIUM CHEZ LES LAPINS ET LES RATS APRES ADMINISTRATION PROLONGEE DE CYCLAMATE DE SODIUMICHIBAGASE H; KOJIMA S; SUENAGA A et al.1972; CHEM. PHARM. BULL.; JAP.; DA. 1972; VOL. 20; NO 6; PP. 1093-1101; BIBL. 16 REF.Serial Issue

Determination of pyridinolcarbamate and its metabolites in rabbit plasma and urine by liquid chromatographySUENAGA, A; IMAMURA, Y; OTAGIRI, M et al.Acta pharmaceutica suecica. 1986, Vol 23, Num 4, pp 245-252, issn 0001-6675Article

Membrane fluidity changes of liposomes in response to various odorants : complexity of membrane composition and variety of adsorption sites for odorantsKASHIWAYANAGI, M; SUENAGA, A; ENOMOTO, S et al.Biophysical journal. 1990, Vol 58, Num 4, pp 887-895, issn 0006-3495, 9 p.Article

Effects of fatty acids on serum binding between furosemide and valproic acidTAKAMURA, N; SHINOZAWA, S; MARUYAMA, T et al.Biological & pharmaceutical bulletin. 1998, Vol 21, Num 2, pp 174-176, issn 0918-6158Article

A comparative study of the interaction of warfarin with human α₁-acid glycoprotein and human albuminOTAGIRI, M; MARUYAMA, T; IMAI, T et al.Journal of pharmacy and pharmacology. 1987, Vol 39, Num 6, pp 416-420, issn 0022-3573Article

Interactions of aldosterone antagonist diuretics with human serum proteinsTAKAMURA, N; MARUYAMA, T; AHMED, S et al.Pharmaceutical research. 1997, Vol 14, Num 4, pp 522-526, issn 0724-8741Article

An immunological method for the detection of captopril-protein conjugateNARAZAKI, R; WATANABE, H; MARUYAMA, T et al.Archives of toxicology. 1998, Vol 72, Num 4, pp 203-206, issn 0340-5761Article

'Split tolerance' induction by intrathymic injection of acetylcholine receptor in a rat model of autoimmune myasthenia gravis ; implications for the design of specific immunotherapiesOHTSURU, I; MATSUO, H; FUKUDOME, T et al.Clinical and experimental immunology (Print). 1995, Vol 102, Num 3, pp 462-467, issn 0009-9104Article

Characterization of a nonsense mutation in the ceruloplasmin gene resulting in diabetes and neurodegenerative diseaseTAKAHASHI, Y; MIYAJIMA, H; SHIRABE, S et al.Human molecular genetics (Print). 1996, Vol 5, Num 1, pp 81-84, issn 0964-6906Article

Mode of interaction of loop diuretics with human serum albumin and characterization of binding siteTAKAMURA, N; HARUTA, A; KODAMA, H et al.Pharmaceutical research. 1996, Vol 13, Num 7, pp 1015-1019, issn 0724-8741Article

Quantitative analysis of the spreading of the mouse trophoblast in vitro : a model for early invasionSUENAGA, A; TACHI, C; TOJO, H et al.Placenta (Eastbourne). 1996, Vol 17, Num 8, pp 583-590, issn 0143-4004Conference Paper

Effects of polychlorinated biphenyls on regeneration of the peripheral nerve in ratsITO, H; YOSHIMURA, T; FURUYA, T et al.Fukuoka-Igaku-Zasshi. 1995, Vol 86, Num 5, pp 267-272, issn 0016-254XArticle

Characterization of a binding site of UCN-01, a novel anticancer drug on α₁-Acid glycoproteinKURATA, N; MATSUSHITA, S; NISHI, K et al.Biological & pharmaceutical bulletin. 2000, Vol 23, Num 7, pp 893-895, issn 0918-6158Article

Seronegative myasthenia gravis associated with atonic urinary bladder and accommodative insufficiencyMATSUI, M; ENOKI, M; MATSUI, Y et al.Journal of the neurological sciences. 1995, Vol 133, Num 1-2, pp 197-199, issn 0022-510XArticle

Drug binding to α₁-acid glycoprotein studied by circular dichroismOTAGIRI, M; YAMAMICHI, R; MARUYAMA, T et al.Pharmaceutical research. 1989, Vol 6, Num 2, pp 156-159, issn 0724-8741Article

Biopharmaceutical studies on pyridinolcarbamate. V: Effect of repeated administration of pyridinolcarbamate on the renal excretion of sulbenicillin in rabbitsSUENAGA, A; NAKAGAWA, H; MING-TE HUANG et al.Acta pharmaceutica suecica. 1985, Vol 22, Num 1, pp 45-52, issn 0001-6675Article

Antibodies to recombinant synaptotagmin and calcium channel subtypes in Lambert-Eaton myasthenic syndromeTAKAMORI, M; TAKAHASHI, M; YASUKAWA, Y et al.Journal of the neurological sciences. 1995, Vol 133, Num 1-2, pp 95-101, issn 0022-510XArticle

Specificity of ω-conotoxin MVIIC-binding and -blocking calcium channel antibodies in Lambert-Eaton myasthenic syndromeNAKAO, Y. K; MOTOMURA, M; SUENAGA, A et al.Journal of neurology. 1999, Vol 246, Num 1, pp 38-44, issn 0340-5354Article

Stabilization of daunorubicin and 4-demethoxydaunorubicin on complexation with octakis(2,6-di-O-methyl)-γ-cyclodextrin in acidic aqueous solutionSUENAGA, A; BEKERS, O; BEIJNEN, J. H et al.International journal of pharmaceutics. 1992, Vol 82, Num 1-2, pp 29-37, issn 0378-5173Article

Effect of cyclodextrin complexation on the chemical stability of doxorubicin and daunorubicin in aqueous solutionsBEKERS, O; BEIJNEN, J. H; VIS, B. J et al.International journal of pharmaceutics. 1991, Vol 72, Num 2, pp 123-130, issn 0378-5173, 8 p.Article